Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum OWC Pharmaceutical Research Corp OWCP

OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company... see more

GREY:OWCP - Post Discussion

OWC Pharmaceutical Research Corp > Massive volume today ...
View:
Post by B8lair8 on Feb 08, 2019 9:13pm

Massive volume today ...

and decline in share price. What's going on here ?
B.
Comment by BeeInveSTING on Feb 10, 2019 2:51pm
I'm also curious... any findings?
Comment by B8lair8 on Feb 11, 2019 12:54am
New executive was hired and granted 1,500,000 stock options, 1% of the float. Only news I could find but I doubt that's enough to warrant selling 13 million shares. Nothing on the OWCP website that I could find. 
Comment by B8lair8 on Feb 11, 2019 1:07am
Find this over on Investors hub. Up to a 500 to 1 reverse split, that would be it. B. FOR the authorization of our Board of Directors to effect one reverse stock split of our outstanding Common Stock, $0.00001 par value per share, at any ratio up to 1-for-500, at such time as our Board of Directors shall determine, in its sole discretion, during the Company’s 2019 fiscal year ending December 31 ...more  
Comment by BeeInveSTING on Feb 12, 2019 10:29pm
Thanks B8lair8! I'm gonna look more into this and see what more I can take away from it. I was hoping that the newly amended regulations allowing medical cannabis exports out of Israel will be a catalyst for this stock.
Comment by bobzuruncle on Dec 29, 2019 6:38pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities